{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:30:49Z","timestamp":1788514249032,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK124647"],"award-info":[{"award-number":["K23DK124647"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.eprac.2025.06.014","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:23:22Z","timestamp":1752607402000},"page":"1239-1246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Real-World Study of Oral Antihyperglycemic Agents as Compared With Basal Insulin in Hospitalized Patients With Type 2 Diabetes"],"prefix":"10.1016","volume":"31","author":[{"given":"Maya","family":"Fayfman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irit","family":"Hochberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Magee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Rashied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliya","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Jagannathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Pasquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo E.","family":"Umpierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"15","key":"10.1016\/j.eprac.2025.06.014_bib1","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1001\/jama.290.15.2041","article-title":"Glucose control and mortality in critically ill patients","volume":"290","author":"Finney","year":"2003","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.eprac.2025.06.014_bib2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.CCM.0000045568.12881.10","article-title":"Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control","volume":"31","author":"Van den Berghe","year":"2003","journal-title":"Crit Care Med"},{"issue":"18","key":"10.1016\/j.eprac.2025.06.014_bib3","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMcp060094","article-title":"Clinical practice. Management of hyperglycemia in the hospital setting","volume":"355","author":"Inzucchi","year":"2006","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.eprac.2025.06.014_bib4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa052521","article-title":"Intensive insulin therapy in the medical ICU","volume":"354","author":"Van den Berghe","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.eprac.2025.06.014_bib5","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2337\/dc10-1407","article-title":"Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery)","volume":"34","author":"Umpierrez","year":"2011","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.eprac.2025.06.014_bib6","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2337\/dc09-9029","article-title":"American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control","volume":"32","author":"Moghissi","year":"2009","journal-title":"Diabetes Care"},{"issue":"supplement_1","key":"10.1016\/j.eprac.2025.06.014_bib7","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.2337\/dc22-S016","article-title":"16. Diabetes care in the hospital: standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2025.06.014_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2011-2098","article-title":"Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline","volume":"97","author":"Umpierrez","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.eprac.2025.06.014_bib9","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1210\/jc.2008-1441","article-title":"Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes","volume":"94","author":"Umpierrez","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.eprac.2025.06.014_bib10","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2337\/dc08-2127","article-title":"Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward","volume":"32","author":"Turchin","year":"2009","journal-title":"Diabetes Care"},{"issue":"15","key":"10.1016\/j.eprac.2025.06.014_bib11","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.2009.496","article-title":"Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction","volume":"301","author":"Kosiborod","year":"2009","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.eprac.2025.06.014_bib12","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2337\/diaspect.27.3.180","article-title":"Pharmacotherapy for hyperglycemia in noncritically ill hospitalized patients","volume":"27","author":"Mendez","year":"2014","journal-title":"Diabetes Spectr"},{"issue":"8","key":"10.1016\/j.eprac.2025.06.014_bib13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11892-017-0884-1","article-title":"Cardiovascular safety of antidiabetic drugs in the hospital setting","volume":"17","author":"Seggelke","year":"2017","journal-title":"Curr Diab Rep"},{"issue":"1","key":"10.1016\/j.eprac.2025.06.014_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/01.QMH.0000344595.48510.cb","article-title":"Assessing the appropriate use of metformin in an inpatient setting and the effectiveness of two pharmacy-based measures to improve guideline adherence","volume":"18","author":"Scotton","year":"2009","journal-title":"Qual Manag Health Care"},{"issue":"7","key":"10.1016\/j.eprac.2025.06.014_bib15","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00268-016-3469-2","article-title":"Insulin-treated patients with diabetes mellitus undergoing emergency abdominal surgery have worse outcomes than patients treated with oral agents","volume":"40","author":"Haltmeier","year":"2016","journal-title":"World J Surg"},{"issue":"4","key":"10.1016\/j.eprac.2025.06.014_bib16","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1515\/jbcpp-2012-0012","article-title":"Drug use evaluation of diabetes mellitus in hospitalized patients of a tertiary care referral hospital","volume":"23","author":"Khalam","year":"2012","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"2","key":"10.1016\/j.eprac.2025.06.014_bib17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S2213-8587(16)30402-8","article-title":"Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial","volume":"5","author":"Pasquel","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"10.1016\/j.eprac.2025.06.014_bib18","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.2337\/dc13-0277","article-title":"Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a pilot, randomized, controlled study","volume":"36","author":"Umpierrez","year":"2013","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2025.06.014_bib19","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2017-000394","article-title":"Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients","volume":"5","author":"Garg","year":"2017","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"4","key":"10.1016\/j.eprac.2025.06.014_bib20","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/dom.13587","article-title":"Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: a multicentre randomized clinical trial","volume":"21","author":"Vellanki","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"suppl 1","key":"10.1016\/j.eprac.2025.06.014_bib21","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","article-title":"The STROBE guidelines","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"issue":"4","key":"10.1016\/j.eprac.2025.06.014_bib22","first-page":"188","article-title":"Charlson Comorbidity Index: ICD-9 update and ICD-10 translation","volume":"12","author":"Glasheen","year":"2019","journal-title":"Am Health Drug Benefits"},{"issue":"5","key":"10.1016\/j.eprac.2025.06.014_bib23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1055\/s-0038-1634956","article-title":"Risk adjustment in outcome assessment: the Charlson Comorbidity Index","volume":"32","author":"D\u2019Hoore","year":"1993","journal-title":"Methods Inf Med"},{"issue":"suppl 1","key":"10.1016\/j.eprac.2025.06.014_bib24","first-page":"S295","article-title":"16. Diabetes care in the hospital: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2025.06.014_bib25","author":"Burgette"},{"issue":"3","key":"10.1016\/j.eprac.2025.06.014_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11892-016-0721-y","article-title":"Stress hyperglycemia during surgery and anesthesia: pathogenesis and clinical implications","volume":"16","author":"Palermo","year":"2016","journal-title":"Curr Diab Rep"},{"issue":"5 suppl","key":"10.1016\/j.eprac.2025.06.014_bib27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/jhm.356","article-title":"Society of Hospital Medicine Glycemic Control Task Force summary: practical recommendations for assessing the impact of glycemic control efforts","volume":"3","author":"Schnipper","year":"2008","journal-title":"J Hosp Med"},{"issue":"2","key":"10.1016\/j.eprac.2025.06.014_bib28","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.metabol.2015.10.014","article-title":"Metformin-associated lactic acidosis: current perspectives on causes and risk","volume":"65","author":"DeFronzo","year":"2016","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.eprac.2025.06.014_bib29","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvab101","article-title":"Outcomes of \u201creal-world\u201d insulin strategies in the management of hospital hyperglycemia","volume":"5","author":"Sadhu","year":"2021","journal-title":"J Endocr Soc"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25009292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25009292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:51:06Z","timestamp":1777618266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25009292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1530891X25009292"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.06.014","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Real-World Study of Oral Antihyperglycemic Agents as Compared With Basal Insulin in Hospitalized Patients With Type 2 Diabetes","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}